Salem Ahmed I, Thau Matthew R, Strom Tobin J, Abbott Andrea M, Saeed Nadia, Almhanna Khaldoun, Hoffe Sarah E, Shridhar Ravi, Karl Richard C, Meredith Kenneth L
Department of Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, USA
University of South Florida Morsani College of Medicine, Tampa, Florida, USA.
Dis Esophagus. 2017 Jan 1;30(1):1-7. doi: 10.1111/dote.12484.
The impact of body weight on outcomes after robotic-assisted esophageal surgery for cancer has not been studied. We examined the short-term operative outcomes in patients according to their body mass index following robotic-assisted Ivor-Lewis esophagectomy at a high-volume tertiary-care referral cancer center and evaluated the safety of robotic surgery in patients with an elevated body mass index. A retrospective review of all patients who underwent robotic-assisted Ivor-Lewis esophagectomy between April 2010 and June 2013 for pathologically confirmed distal esophageal cancer was conducted. Patient demographics, clinicopathologic data, and operative outcomes were collected. We stratified body mass index at admission for surgery according to World Health Organization criteria; normal range is defined as a body mass index range of 18.5-24.9 kg/m2. Overweight is defined as a body mass index range of 25.0-29.9 kg/m2 and obesity is defined as a body mass index of 30 kg/m2 and above. Statistics were calculated using Pearson's Chi-square and Pearson's correlation coefficient tests with a P-value of 0.05 or less for significance. One hundred and twenty-nine patients (103 men, 26 women) with median age of 67 (30-84) years were included. The majority of patients, 76% (N = 98) received neoadjuvant therapy. When stratified by body mass index, 28 (22%) were normal weight, 56 (43%) were overweight, and 45 (35%) were obese. All patients had R0 resection. Median operating room time was 407 (239-694) minutes. When stratified by body mass index, medians of operating room time across the normal weight, overweight and obese groups were 387 (254-660) minutes, 395 (310-645) minutes and 445 (239-694), respectively. Median estimated blood loss (EBL) was 150 (25-600) cc. When stratified by body mass index, medians of EBL across the normal weight, overweight and obese groups were 100 (50-500) cc, 150 (25-600) cc and 150 (25-600), respectively. Obesity significantly correlated with longer operating room time (P = 0.05) but without significant increased EBL (P = 0.348). Among the three body mass index groups there was no difference in postoperative complications including thrombotic events (pulmonary embolism and deep venous thrombosis) (P = 0.266), pneumonia (P = 0.189), anastomotic leak (P = 0.090), wound infection (P = 0.390), any cardiac events (P = 0.793) or 30 days mortality (P = 0.414). Our data study demonstrates that patients with esophageal cancer and an elevated body mass index undergoing robotic-assisted Ivor-Lewis esophagectomy have increased operative times but no significantly increased EBL during the procedure. Other potential morbidities did not differ with the robotic approach.
体重对机器人辅助食管癌手术后结局的影响尚未得到研究。我们在一家大型三级医疗转诊癌症中心,根据患者的体重指数,研究了机器人辅助Ivor-Lewis食管切除术后患者的短期手术结局,并评估了体重指数升高患者接受机器人手术的安全性。对2010年4月至2013年6月间因病理确诊为远端食管癌而接受机器人辅助Ivor-Lewis食管切除术的所有患者进行了回顾性研究。收集了患者的人口统计学资料、临床病理数据和手术结局。我们根据世界卫生组织标准对手术入院时的体重指数进行分层;正常范围定义为体重指数在18.5 - 24.9kg/m²之间。超重定义为体重指数在25.0 - 29.9kg/m²之间,肥胖定义为体重指数30kg/m²及以上。使用Pearson卡方检验和Pearson相关系数检验进行统计分析,P值小于或等于0.05具有统计学意义。纳入了129例患者(103例男性,26例女性),中位年龄为67岁(30 - 84岁)。大多数患者,76%(N = 98)接受了新辅助治疗。按体重指数分层时,28例(22%)体重正常,56例(43%)超重,45例(35%)肥胖。所有患者均实现R0切除。中位手术时间为407分钟(239 - 694分钟)。按体重指数分层时,体重正常、超重和肥胖组的手术时间中位数分别为387分钟(254 - 660分钟)、395分钟(310 - 645分钟)和445分钟(239 - 694分钟)。中位估计失血量(EBL)为150cc(25 - 600cc)。按体重指数分层时,体重正常、超重和肥胖组的EBL中位数分别为100cc(50 - 500cc)、150cc(25 - 600cc)和150cc(25 - 600cc)。肥胖与较长的手术时间显著相关(P = 0.05),但EBL无显著增加(P = 0.348)。在三个体重指数组中,术后并发症包括血栓形成事件(肺栓塞和深静脉血栓形成)(P = 0.266)、肺炎(P = 0.189)、吻合口漏(P = 0.090)、伤口感染(P = 0.390)、任何心脏事件(P = 0.793)或30天死亡率(P = 0.414)均无差异。我们的数据研究表明,接受机器人辅助Ivor-Lewis食管切除术的体重指数升高的食管癌患者手术时间增加,但术中EBL无显著增加。其他潜在的发病情况在机器人手术方式下并无差异。